# Individually Tailored Prophylaxis in Patients With Severe Hemophilia A

> **NCT00995046** · NA · TERMINATED · sponsor: **Hospices Civils de Lyon** · enrollment: 5 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** FVIII
- **DRUG:** FVIII

## Key facts

- **NCT ID:** NCT00995046
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00995046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00995046, "Individually Tailored Prophylaxis in Patients With Severe Hemophilia A". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00995046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*